Multimedia
Featured Video
Discover NIMH: Drug Discovery and Development
One of the most exciting recent breakthroughs from research funded by the National Institute of Mental Health (NIMH) is the development of a fast-acting medication for treatment-resistant depression based on ketamine. This treatment is bringing new hope to people and families affected by major depression.
Health Topics
-
Mental Health Minute: Bipolar Disorder in Adults
-
NIMH Livestream Event on Seasonal Affective Disorder
-
Macrophage Infection by HIV: Implications for Pathogenesis and Cure: Day Two
-
Macrophage Infection by HIV: Implications for Pathogenesis and Cure: Day One
Populations
-
Advancing Evidence-Based Interventions to Improve Access to Mental Health Services for LGBTQ+ Youth
-
Mental Health Minute: Stress and Anxiety in Adolescents
-
Severe Irritability
-
NIMH Expert Dr. Krystal Lewis Discusses Coping with the Pandemic and Re-Entry Stress
Research
-
Advancing Evidence-Based Interventions to Improve Access to Mental Health Services for LGBTQ+ Youth
-
Technical Assistance Webinar: Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low-and Middle-Income Countries
-
NIMH Livestream Event on Suicide Prevention During COVID: A Continuing Priority
-
The NIMH Director’s Innovation Speaker Series: Developmental Cognitive Neuroscience in the Era of Big Data
